Adipose-derived stromal stem cells (ASCs) as a new regenerative immediate therapy combating coronavirus (COVID-19)-induced pneumonia
Pietro Gentile, Aris Sterodimas
Abstract
KEYWORDS: Mesenchymal stem cells coronavirusmesenchymal stem cells COVID-19adipose-derived stem cells coronavirusstem cell therapy COVID-19cellular therapy COVID-19
Topics & Concepts
Stem cellMesenchymal stem cellStem-cell therapyPneumoniaCoronavirus disease 2019 (COVID-19)Stromal cellCoronavirusMedicineCell therapyRegenerative medicineImmunologyBiologyVirologyCancer researchPathologyCell biologyInternal medicineDiseaseInfectious disease (medical specialty)Mesenchymal stem cell researchLong-Term Effects of COVID-19COVID-19 and healthcare impacts